Pharma Journalist -

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced it has entered into a Collaborative Research Agreement (“CRA”) with Yale…
Read More...

SMi Reports: Inaugural conference set to explore contamination control in pharmaceutical aseptic manufacturing using cleanroom and barrier technologies this October The inaugural…
Read More...

Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and…
Read More...

Eidos Therapeutics, Inc. confirmed that it has received a non-binding proposal dated August 8, 2019 from BridgeBio Pharma, Inc., the parent entity of the Company’s majority stockholder,…
Read More...

Onconova Therapeutics announced that they have formed a collaboration to utilize the Mission Bio Tapestri Platform for targeted single-cell DNA analysis to study Onconova’s novel cancer…
Read More...

Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment, announced that it has entered into a clinical…
Read More...

Jazz Pharmaceuticals plc announced the acquisition of Cavion, Inc. through a merger with a Jazz subsidiary. Under the terms of the agreement, the former Cavion shareholders receive an…
Read More...

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for…
Read More...

RELIEF THERAPEUTICS Holding SA announces that it has executed a binding Share Exchange Agreement (the “Agreement”) with Sonnet BioTherapeutics, Inc. ("Sonnet"). Sonnet is a privately…
Read More...

SMi Reports: Learn from key opinion leaders at the Respiratory Drug Delivery conference this December SMi Group are delighted to announce their inaugural conference Respiratory Drug…
Read More...